Masticatory efficiency in complete denture and single implant-retained mandibular overdenture wearers with different occlusion schemes: A randomized clinical trial
Rocha, Cibele O.M., Longhini, Diogo, Pereira, Rodrigo P., Lima, Amanda L.O., Bonafé, Fernanda S.S., Arioli Filho, João N.
Published in The Journal of prosthetic dentistry (01.06.2023)
Published in The Journal of prosthetic dentistry (01.06.2023)
Get full text
Journal Article
Superoxide Dismutase Activity in Adriamycin-Induced Cardiotoxicity in Humans: A Potential Novel Tool for Risk Stratification
Rohde, Luis E., Belló-Klein, Adriane, Pereira, Rodrigo P., Mazzotti, Nicolle G., Geib, Guilherme, Weber, Cristiane, Silva, Luis F., Clausell, Nadine
Published in Journal of cardiac failure (01.04.2005)
Published in Journal of cardiac failure (01.04.2005)
Get full text
Journal Article
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAF V600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
Ascierto, Paolo A, Stroyakovskiy, Daniil, Gogas, Helen, Robert, Caroline, Lewis, Karl, Protsenko, Svetlana, Pereira, Rodrigo P, Eigentler, Thomas, Rutkowski, Piotr, Demidov, Lev, Zhukova, Natalia, Schachter, Jacob, Yan, Yibing, Caro, Ivor, Hertig, Christian, Xue, Cloris, Kusters, Lieke, McArthur, Grant A, Gutzmer, Ralf
Published in The lancet oncology (01.01.2023)
Published in The lancet oncology (01.01.2023)
Get full text
Journal Article
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
Ascierto, Paolo A, Stroyakovskiy, Daniil, Gogas, Helen, Robert, Caroline, Lewis, Karl, Protsenko, Svetlana, Pereira, Rodrigo P, Eigentler, Thomas, Rutkowski, Piotr, Demidov, Lev, Zhukova, Natalia, Schachter, Jacob, Yan, Yibing, Caro, Ivor, Hertig, Christian, Xue, Cloris, Kusters, Lieke, McArthur, Grant A, Gutzmer, Ralf
Published in The lancet oncology (01.01.2023)
Published in The lancet oncology (01.01.2023)
Get full text
Journal Article
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF V600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
Gutzmer, Ralf, Stroyakovskiy, Daniil, Gogas, Helen, Robert, Caroline, Lewis, Karl, Protsenko, Svetlana, Pereira, Rodrigo P, Eigentler, Thomas, Rutkowski, Piotr, Demidov, Lev, Manikhas, Georgy Moiseevich, Yan, Yibing, Huang, Kuan-Chieh, Uyei, Anne, McNally, Virginia, McArthur, Grant A, Ascierto, Paolo A
Published in The Lancet (British edition) (13.06.2020)
Published in The Lancet (British edition) (13.06.2020)
Get full text
Journal Article
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
Gutzmer, Ralf, Stroyakovskiy, Daniil, Gogas, Helen, Robert, Caroline, Lewis, Karl, Protsenko, Svetlana, Pereira, Rodrigo P, Eigentler, Thomas, Rutkowski, Piotr, Demidov, Lev, Manikhas, Georgy Moiseevich, Yan, Yibing, Huang, Kuan-Chieh, Uyei, Anne, McNally, Virginia, McArthur, Grant A, Ascierto, Paolo A
Published in The Lancet (British edition) (13.06.2020)
Published in The Lancet (British edition) (13.06.2020)
Get full text
Journal Article